Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll Emerging roles of SUMO modification in arthritis Yan D; Davis FJ; Sharrocks AD; Im HJGene  2010[Oct]; 466 (1-2): 1-15Dynamic modification involving small ubiquitin-like modifier (SUMO) has emerged  as a new mechanism of protein regulation in mammalian biology. Sumoylation is an  ATP-dependent, reversible post-translational modification which occurs under both  basal and stressful cellular conditions. Sumoylation profoundly influences  protein functions and pertinent biological processes. For example, sumoylation  modulates multiple components in the NFkappaB pathway and exerts an  anti-inflammatory effect. Likewise, sumoylation of peroxisome  proliferator-activated receptor gamma (PPARgamma) augments its anti-inflammatory  activity. Current evidence suggests a role of sumoylation for resistance to  apoptosis in synovial fibroblasts. Dynamic SUMO regulation controls the  biological outcomes initiated by various growth factors involved in cartilage  homeostasis, including basic fibroblast growth factors (bFGF or FGF-2),  transforming growth factor-beta (TGF-beta) and insulin-like growth factor-1  (IGF-1). The impact of these growth factors on cartilage are through  sumoylation-dependent control of the transcription factors (e.g., Smad, Elk-1,  HIF-1) that are key regulators of matrix components (e.g., aggrecan, collagen) or  cartilage-degrading enzymes (e.g., MMPs, aggrecanases). Thus, SUMO modification  appears to profoundly affect chondrocyte and synovial fibroblast biology,  including cell survival, inflammatory responses, matrix metabolism and hypoxic  responses. More recently, evidence suggests that, in addition to their nuclear  roles, the SUMO pathways play crucial roles in mitochondrial activity, cellular  senescence, and autophagy. With an increasing number of reports linking SUMO to  human diseases like arthritis, it is probable that novel and equally important  functions of the sumoylation pathway will be elucidated in the near future.|Animals[MESH]|Arthritis/*genetics[MESH]|Autophagy[MESH]|Cellular Senescence[MESH]|Chondrocytes/metabolism[MESH]|Humans[MESH]|Inflammation/genetics[MESH]|Models, Biological[MESH]|Protein Processing, Post-Translational[MESH]|Signal Transduction[MESH]|Small Ubiquitin-Related Modifier Proteins/genetics[MESH]|Synovial Membrane/metabolism[MESH] |